专利检索 ap:("INSERM (Institut National de la Santé et de la Recherche Médicale)" OR "Institut Jean Paoli & Irène Calmettes" OR "Université d'Aix Marseille" OR "Centre National de la Recherche Scientifique (CNRS)") AND inv:"AURRAND-LIONS, Michel" 第 1 页

1.

发明公开
NEW BIOMARKER FOR OUTCOME IN AML 审中-公开
标题翻译：新的生物标志物在反洗钱中取得成效

公开(公告)号：EP3277841A1

公开(公告)日：2018-02-07

申请号：EP16723255.2

申请日：2016-03-30

申请人： INSERM (Institut National de la Santé et de la Recherche Médicale) , Institut Jean Paoli & Irène Calmettes , Université d'Aix Marseille , Centre National de la Recherche Scientifique (CNRS)

发明人： AURRAND-LIONS, Michel , DE GRANDIS, Maria , VEY, Norbert

IPC分类号： C12Q1/68

CPC分类号： C12Q1/6886 , C12Q2600/118 , C12Q2600/158 , G01N33/57426 , G01N33/57492 , G01N2400/00 , G01N2800/52

摘要： The present invention relates to a method for predicting the survival time of a patient suffering from acute myeloid leukemia (AML) comprising i) determining the frequency of JAM-C expressing LSCs in a sample obtained from the patient ii) comparing the frequency determined at step i) with its predetermined reference value and iii) providing a good prognosis when the frequency determined at step i) is lower than its predetermined reference value, or 10 providing a bad prognosis when the frequency determined at step i) is higher than its predetermined reference value.